U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 2 of 2 results

USNIC ACID

MORE DETAILS

  0W584PFJ77

Status:
Possibly Marketed Outside US
First approved in 2014
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Junin virus
3
Tacaribe virus
3
HCT-116
7
MCF7
21
A549
13
Conditions:
Argentine hemorrhagic fever
2
Cancer
592
Non-small cell lung cancer
206
Since its first isolation in 1844, usnic acid has become the most extensively studied lichen metabolite and one of the few that are commercially available. Lichens belonging to usnic acid-containing genera have been used as crude drugs throughout the...

SODIUM USNATE

MORE DETAILS

  90CQX661TE

Status:
Possibly Marketed Outside US
First approved in 2014
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Junin virus
3
Tacaribe virus
3
HCT-116
7
MCF7
21
A549
13
Conditions:
Argentine hemorrhagic fever
2
Cancer
592
Non-small cell lung cancer
206
Since its first isolation in 1844, usnic acid has become the most extensively studied lichen metabolite and one of the few that are commercially available. Lichens belonging to usnic acid-containing genera have been used as crude drugs throughout the...
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966